159 related articles for article (PubMed ID: 17846559)
1. Low sensitivity of total lymphocyte count as a surrogate marker to identify antepartum and postpartum Indian women who require antiretroviral therapy.
Gupta A; Gupte N; Bhosale R; Kakrani A; Kulkarni V; Nayak U; Thakar M; Sastry J; Bollinger RC;
J Acquir Immune Defic Syndr; 2007 Nov; 46(3):338-42. PubMed ID: 17846559
[TBL] [Abstract][Full Text] [Related]
2. Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings.
Obirikorang C; Quaye L; Acheampong I
BMC Infect Dis; 2012 Jun; 12():128. PubMed ID: 22676809
[TBL] [Abstract][Full Text] [Related]
3. Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings.
Spacek LA; Griswold M; Quinn TC; Moore RD
AIDS; 2003 Jun; 17(9):1311-7. PubMed ID: 12799552
[TBL] [Abstract][Full Text] [Related]
4. Total lymphocyte count: a surrogate marker for predicting CD4+ count in enrolled process for antiretroviral therapy in resource-limited settings.
Susaengrat W; Mitchai M; Leerattanapetch N
J Med Assoc Thai; 2008 Oct; 91(10):1514-7. PubMed ID: 18972893
[TBL] [Abstract][Full Text] [Related]
5. Total lymphocyte count as a surrogate marker for CD4+ t cell count in initiating antiretroviral therapy at Kenyatta National Hospital, Nairobi.
Gitura B; Joshi MD; Lule GN; Anzala O
East Afr Med J; 2007 Oct; 84(10):466-72. PubMed ID: 18232267
[TBL] [Abstract][Full Text] [Related]
6. CD4+ cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource-limited settings.
Carter RJ; Dugan K; El-Sadr WM; Myer L; Otieno J; Pungpapong N; Toro PL; Abrams EJ;
J Acquir Immune Defic Syndr; 2010 Nov; 55(3):404-10. PubMed ID: 20595905
[TBL] [Abstract][Full Text] [Related]
7. Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings.
Mahajan AP; Hogan JW; Snyder B; Kumarasamy N; Mehta K; Solomon S; Carpenter CC; Mayer KH; Flanigan TP
J Acquir Immune Defic Syndr; 2004 May; 36(1):567-75. PubMed ID: 15097299
[TBL] [Abstract][Full Text] [Related]
8. Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda.
Kamya MR; Semitala FC; Quinn TC; Ronald A; Njama-Meya D; Mayanja-Kizza H; Katabira ET; Spacek LA
Afr Health Sci; 2004 Aug; 4(2):94-101. PubMed ID: 15477187
[TBL] [Abstract][Full Text] [Related]
9. Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries.
Kumarasamy N; Mahajan AP; Flanigan TP; Hemalatha R; Mayer KH; Carpenter CC; Thyagarajan SP; Solomon S
J Acquir Immune Defic Syndr; 2002 Dec; 31(4):378-83. PubMed ID: 12447007
[TBL] [Abstract][Full Text] [Related]
10. Evaluating total lymphocyte count as a surrogate marker for CD4 cell count in the management of HIV-infected patients in resource-limited settings: a study from China.
Chen J; Li W; Huang X; Guo C; Zou R; Yang Q; Zhang H; Zhang T; Chen H; Wu H
PLoS One; 2013; 8(7):e69704. PubMed ID: 23874985
[TBL] [Abstract][Full Text] [Related]
11. Total lymphocyte count and World Health Organization pediatric clinical stage as markers to assess need to initiate antiretroviral therapy among human immunodeficiency virus-infected children in Moshi, Northern Tanzania.
Johnson OO; Benjamin DK; Benjamin DK; Schimana W; Tillekeratne LG; Crump JA; Landman KZ; Kinabo GD; Mmbaga B; Msuya LJ; Shao JF; Swai ME; Cunningham CK
Pediatr Infect Dis J; 2009 Jun; 28(6):493-7. PubMed ID: 19436238
[TBL] [Abstract][Full Text] [Related]
12. Correlation analysis on total lymphocyte count and CD4 count in HIV-infected patients: a retrospective evaluation.
Wang Y; Liang S; Yu E; Guo J; Li Z; Wang Z; Du Y
J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):712. PubMed ID: 22038367
[TBL] [Abstract][Full Text] [Related]
13. Comparison of CD4 cell count, viral load, and other markers for the prediction of mortality among HIV-1-infected Kenyan pregnant women.
Brown ER; Otieno P; Mbori-Ngacha DA; Farquhar C; Obimbo EM; Nduati R; Overbaugh J; John-Stewart GC
J Infect Dis; 2009 May; 199(9):1292-300. PubMed ID: 19317628
[TBL] [Abstract][Full Text] [Related]
14. Utility of total lymphocyte count as a surrogate marker for CD4 counts in HIV-1 infected children in Kenya.
Githinji N; Maleche-Obimbo E; Nderitu M; Wamalwa DC; Mbori-Ngacha D
BMC Infect Dis; 2011 Sep; 11():259. PubMed ID: 21961890
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
16. Total lymphocyte count as a tool for timing opportunistic infection prophylaxis in resource-limited settings: a study from India.
Srirangaraj S; Venkatesha D
J Infect Dev Ctries; 2010 Oct; 4(10):645-9. PubMed ID: 21045357
[TBL] [Abstract][Full Text] [Related]
17. Use of total lymphocyte count to predict absolute CD4 count in HIV-seropositive cases.
Gautam H; Saini S; Bhalla P; Singh T
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(5):292-5. PubMed ID: 20923954
[TBL] [Abstract][Full Text] [Related]
18. Maternal Motivation to Take Preventive Therapy in Antepartum and Postpartum Among HIV-Positive Pregnant Women in South Africa: A Choice Experiment.
Kim HY; Dowdy DW; Martinson NA; Kerrigan D; Tudor C; Golub J; Bridges JFP; Hanrahan CF
AIDS Behav; 2019 Jul; 23(7):1689-1697. PubMed ID: 30415430
[TBL] [Abstract][Full Text] [Related]
19. Correlation among total lymphocyte count, absolute CD4+ count, and CD4+ percentage in a group of HIV-1-infected South African patients.
van der Ryst E; Kotze M; Joubert G; Steyn M; Pieters H; van der Westhuizen M; van Staden M; Venter C
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):238-44. PubMed ID: 9803965
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
